TOP2A and cervical cancer: Furthermore, immunohistochemistry staining (Fig 1) revealed that, among 145 patients seeking cervical cancer care, 103 (71.0%) and 61 (42.1%) strongly expressed p16 (p16+) and TOP2A (TOP2A++) proteins, respectively (Table 1).